Optimizing tumor immune response through combination of radiation and immunotherapy Alissar El ChediakAli ShamseddineYoussef H. Zeidan Review Article 21 August 2017 Article: 165
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature Stella CapriglioneDaniela LuveroRoberto Angioli Review Article 20 August 2017 Article: 164
Activity of cabazitaxel in patients with metastatic castration-resistant prostate cancer after treatment with single or dual regimens of novel androgen receptor-targeting agents Yukari BandoNobuyuki HinataMasato Fujisawa Original Paper 17 August 2017 Article: 163
High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience Iwona Filipczak-BryniarskaRoger M. KrzyzewskiKrzysztof Krzemieniecki Original Paper Open access 17 August 2017 Article: 162
Bcl-2 antigen expression in luminal A and triple-negative breast cancer Carla Solange Escórcio-DouradoLuana Mota MartinsBenedito Borges da Silva Original Paper 11 August 2017 Article: 161
Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting William K. OhRaymond MiaoMei Sheng Duh Original Paper Open access 10 August 2017 Article: 160
Lung cancer as a cardiotoxic state: a review David Pérez-CallejoMaría TorrenteMariano Provencio Review Article 09 August 2017 Article: 159
ZAR1 knockdown promotes the differentiation of human neuroblastoma cells by suppression of MYCN expression Yosuke WatanabeYoshiaki IshizukaKyoko Fujiwara Original Paper 08 August 2017 Article: 158
Tolerability and efficacy of concurrent chemoradiotherapy comparing carboplatin/paclitaxel versus platinum/5-FU regimen for locally advanced esophageal and esophagogastric junction cancers Amorn TamtaiChuleeporn JiarpinitnunNuttapong Ngamphaiboon Original Paper 07 August 2017 Article: 157
A comparative study of Ki-67 antigen expression between luminal A and triple-negative subtypes of breast cancer Umbelina Soares BorgesDanylo Rafhael Costa-SilvaPedro Vitor Lopes-Costa Original Paper 05 August 2017 Article: 156
Effect of a 12-week integrative oncology intervention on gastro-intestinal concerns in patients with gynecological and breast cancer undergoing chemotherapy Ilanit Shalom-SharabiLital Keinan-BokerEran Ben-Arye Short Communication 04 August 2017 Article: 155
Incidence and identification of risk factors for trastuzumab-induced cardiotoxicity in breast cancer patients: an audit of a single “real-world” setting Grace H. TangSergio A. AcunaChristine Brezden-Masley Original Paper 04 August 2017 Article: 154
Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort Ying ChenDavid R. LairsonXianglin L. Du Original Paper 03 August 2017 Article: 153
Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer Domenico CanteEdoardo PetrucciPierfrancesco Franco Original Paper 03 August 2017 Article: 152
Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma Silvia R. GrazianiCarolina G. VitalRaul C. Maranhão Original Paper 29 July 2017 Article: 151
Predictors of recurrent hospital admissions among prostate cancer survivors Jerome GnanarajZarish UmarWaseem Khaliq Original Paper 27 July 2017 Article: 150
Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region Carsten NiederMohsan A. SyedJan Norum Original Paper 26 July 2017 Article: 149
Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma Jureeporn ChuerduangphuiChamsai PientongTipaya Ekalaksananan Original Paper 24 July 2017 Article: 148
